MONOGIN® Gel
Therapeutic areas
Pharmaceutical form
Dermatological gel
MONOGIN® dermatological gel is a CE medical device useful in the adult population in all cases of vulvitis and balanitis, as it limits the proliferation of pathogenic species and restores the physiological pH of the treated areas. It exerts a barrier effect that protects against the risk of secondary infections, promoting the healing process and the restoration of physiological conditions. It can be applied to mucous membranes and skin, even in the presence of lesions.
Composition
Hydroxyethyl cellulose 2.50 g; glycerol 2.00 g; potassium chloride 0.20 g; polyhexamethylenebiguanide hydrochloride (PHMB) 0.15 g; sodium edetate 0.15 g; lactic acid 0.01g; purified water to taste at 100 ml.
Recommended Posology
Unless otherwise prescribed by a doctor, it is recommended to apply the gel to the area to be treated, with a light massage, 1 or 2 times a day (morning and evening) for at least 7 days.
It is a CE0477 medical device. 30ml tube. Read the warnings or instructions for use carefully.
Authorization by the Ministry of Health 02/26/2024